Management Board Meets to Discuss EMA Premises in Amsterdam

Published on: 

Applied Clinical Trials

The European Medicines Agency’s Management Board met to discuss EMA’s future premises in Amsterdam. With the anticipated move in March of 2019, the EMA needs to have a designated location to operate, but with this discussion it has been seen that the building will not be completed in time and they will have to settle upon a temporary premises.

Read the full release here